TrialPanorama/TrialPanorama-database huggingface dataset:
Study: 20436517

Group type: EXPERIMENTAL
Intervention: r-metHuSCF (ancestim) + filgrastim (r-metHuG-CSF)
Number of subjects: 32

Group type: COMPARATOR
Intervention: Chemotherapy + filgrastim (r-metHuG-CSF)
Number of subjects: 32

Group type: EXPERIMENTAL
Intervention: Both arms (A and B)
Number of subjects: 32

Group type: COMPARATOR
Intervention: Arm B (Chemotherapy + filgrastim)
Number of subjects: 32
Study: 18360781

Group type: EXPERIMENTAL
Intervention: Aggressive BP lowering (MAP < 110 mmHg)
Number of subjects: 42

Group type: COMPARATOR
Intervention: Standard BP treatment (MAP 110-130 mmHg)
Number of subjects: 42
Study: 16434761

Group type: EXPERIMENTAL
Intervention: ProSeal LMA
Number of subjects: 150

Group type: EXPERIMENTAL
Intervention: SLIPA
Number of subjects: 150

Group type: COMPARATOR
Intervention: Tracheal Tube (TT)
Number of subjects: 150
Study: 15349658

Group type: EXPERIMENTAL
Intervention: IgY toothpaste
Number of subjects: 140

Group type: COMPARATOR
Intervention: Control toothpaste
Number of subjects: 140
Study: 11139951

Group type: EXPERIMENTAL
Intervention: Overdrive pacing + Rest Rate
Number of subjects: 78

Group type: COMPARATOR
Intervention: Standard DDDR
Number of subjects: 78
Study: 9316188

Group type: EXPERIMENTAL
Intervention: Relaxation training
Number of subjects: 37

Group type: EXPERIMENTAL
Intervention: Beta-adrenergic blockade
Number of subjects: 37

Group type: COMPARATOR
Intervention: Sham relaxation
Number of subjects: 37
Study: 8330599

Group type: EXPERIMENTAL
Intervention: i.m. buprenorphine 0.3 mg
Number of subjects: 60

Group type: EXPERIMENTAL
Intervention: i.m. buprenorphine 0.3 mg (prophylactic)
Number of subjects: 60

Group type: COMPARATOR
Intervention: i.m. saline
Number of subjects: 60
Study: 3550299

Group type: EXPERIMENTAL
Intervention: Prostacyclin (12.5 ng/kg/min before cardiopulmonary bypass and 25 ng/kg/min during cardiopulmonary bypass)
Number of subjects: 100

Group type: COMPARATOR
Intervention: Buffer-diluent (control group)
Number of subjects: 100
Study: 29766651

Group type: EXPERIMENTAL
Intervention: Silane application only (SIL)
Number of subjects: 40

Group type: EXPERIMENTAL
Intervention: Silane application followed by adhesive (SILXP‐XP Bond)
Number of subjects: 40

Group type: EXPERIMENTAL
Intervention: Silane‐containing adhesive (SBU‐ScotchBond Universal)
Number of subjects: 40

Group type: EXPERIMENTAL
Intervention: Silane application followed by silane‐containing adhesive (SILSBU)
Number of subjects: 40
Study: 27060419

Group type: EXPERIMENTAL
Intervention: Short and intensive speech therapy (6 hours over 3-4 days)
Number of subjects: 5
Study: 23494105

Group type: EXPERIMENTAL
Intervention: Pancreatic juice replacement (R)
Number of subjects: 46

Group type: COMPARATOR
Intervention: Pancreatic juice non-replacement (NR)
Number of subjects: 46
Study: 24299462

Group type: EXPERIMENTAL
Intervention: Estimated glomerular filtration rate (eGFR)
Number of subjects: 669

Group type: EXPERIMENTAL
Intervention: Restrictive left ventricular filling pattern (RF)
Number of subjects: 669
Study: 20953530

Group type: EXPERIMENTAL
Intervention: Tubeless PCNL with double‐J stent (Group 1)
Number of subjects: 148

Group type: COMPARATOR
Intervention: Tubeless PCNL with external ureteral catheter (Group 2)
Number of subjects: 148
Study: 18655752

Group type: EXPERIMENTAL
Intervention: Rosuvastatin
Number of subjects: 80

Group type: EXPERIMENTAL
Intervention: Atorvastatin
Number of subjects: 80
Study: 16216530

Group type: EXPERIMENTAL
Intervention: ln-SHBG among HT nonusers
Number of subjects: 383

Group type: EXPERIMENTAL
Intervention: ln-testosterone among HT nonusers
Number of subjects: 383

Group type: EXPERIMENTAL
Intervention: ln-SHBG among HT nonusers who developed CVD
Number of subjects: 383

Group type: EXPERIMENTAL
Intervention: ln-SHBG among HT nonusers who remained CVD-free
Number of subjects: 383

Group type: EXPERIMENTAL
Intervention: ln-SHBG among lean women
Number of subjects: 383

Group type: EXPERIMENTAL
Intervention: Sex hormones among HT users
Number of subjects: 383
Study: 14567818

Group type: EXPERIMENTAL
Intervention: Tension-free vaginal tape (TVT) procedure
Number of subjects: 46

Group type: COMPARATOR
Intervention: Laparoscopic Burch colposuspension
Number of subjects: 46
Study: 9170894

Group type: EXPERIMENTAL
Intervention: Zinc gluconate lozenges, administered every 2 hours for the duration of cold symptoms
Number of subjects: 0

Group type: COMPARATOR
Intervention: Placebo lozenges, administered every 2 hours for the duration of cold symptoms
Number of subjects: 0
Study: 8416062

Group type: EXPERIMENTAL
Intervention: Intact target stimuli
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Degraded target stimuli (removing 33% of elements or overlaying a matrix of dots)
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Related targets
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Unrelated targets
Number of subjects: 0
Study: 4025853

Group type: EXPERIMENTAL
Intervention: Etomidate (0.4 mg/kg)
Number of subjects: 83

Group type: COMPARATOR
Intervention: Thiopental (4 mg/kg)
Number of subjects: 83

Group type: EXPERIMENTAL
Intervention: Fentanyl pretreatment (100 micrograms)
Number of subjects: 83

Group type: COMPARATOR
Intervention: Normal saline pretreatment
Number of subjects: 83

Group type: EXPERIMENTAL
Intervention: Both etomidate and thiopental
Number of subjects: 83
Study: 31290696

Group type: EXPERIMENTAL
Intervention: Basketball training (2 hours, 5 days a week for 8 weeks)
Number of subjects: 0

Group type: COMPARATOR
Intervention: Control group (adolescents who did not regularly exercise)
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Basketball training
Number of subjects: 0
Study: 31499457

Group type: EXPERIMENTAL
Intervention: Active training condition (85-dB white noise burst paired with fearful faces)
Number of subjects: 144

Group type: COMPARATOR
Intervention: Active control condition (white noise presented randomly)
Number of subjects: 144

Group type: COMPARATOR
Intervention: No-sound condition
Number of subjects: 144
Study: 28219426

Group type: EXPERIMENTAL
Intervention: Topical nepafenac 0.3%
Number of subjects: 1000

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 1000
Study: 24690432

Group type: EXPERIMENTAL
Intervention: Hypoxic resistance training (FiO2 = 12.7%)
Number of subjects: 13

Group type: COMPARATOR
Intervention: Normoxic resistance training (FiO2 = 20.9%)
Number of subjects: 13

Group type: EXPERIMENTAL
Intervention: Both hypoxic and normoxic resistance training
Number of subjects: 13
Study: 23932066

Group type: EXPERIMENTAL
Intervention: ropinirole PR
Number of subjects: 345

Group type: COMPARATOR
Intervention: placebo
Number of subjects: 345
Study: 22117983

Group type: EXPERIMENTAL
Intervention: Wheat dextrin (15 g/day)
Number of subjects: 40

Group type: COMPARATOR
Intervention: Placebo (15 g/day)
Number of subjects: 40
Study: 19213680

Group type: EXPERIMENTAL
Intervention: Dronedarone, 400 mg twice a day
Number of subjects: 4628

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 4628
Study: 16838229

Group type: EXPERIMENTAL
Intervention: Nitazoxanide (500 mg 2 times per day for 7 days)
Number of subjects: 104

Group type: EXPERIMENTAL
Intervention: Nitazoxanide (500 mg 2 times per day for 10 days)
Number of subjects: 104

Group type: COMPARATOR
Intervention: Metronidazole (250 mg 4 times per day for 10 days)
Number of subjects: 104
Study: 12782840

Group type: EXPERIMENTAL
Intervention: Optic disc hemorrhage detection using stereo flicker chronoscopy of stereophotograph pairs
Number of subjects: 167

Group type: COMPARATOR
Intervention: Global visual field indices, AGIS scores, intraocular pressures
Number of subjects: 167
Study: 10855437

Group type: EXPERIMENTAL
Intervention: Amputee Mobility Aid (AMA)
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Mechanical knee of the AMA
Number of subjects: 0

Group type: COMPARATOR
Intervention: Pneumatic Post‐Amputation Mobility aid (PPAM aid)
Number of subjects: 0
Study: 9109584

Group type: EXPERIMENTAL
Intervention: Early treatment with headgear
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Early treatment with modified bionator
Number of subjects: 0

Group type: COMPARATOR
Intervention: Observation (Control)
Number of subjects: 0
Study: 8249589

Group type: EXPERIMENTAL
Intervention: Retrobulbar bupivacaine block
Number of subjects: 32

Group type: COMPARATOR
Intervention: Control group (no retrobulbar bupivacaine)
Number of subjects: 32
Study: 3813141

Group type: EXPERIMENTAL
Intervention: Oral diazepam premedication
Number of subjects: 0

Group type: COMPARATOR
Intervention: Intramuscular diazepam premedication
Number of subjects: 0
Study: 30615795

Group type: EXPERIMENTAL
Intervention: Dexmedetomidine
Number of subjects: 38

Group type: COMPARATOR
Intervention: Propofol
Number of subjects: 38
Study: 26810362

Group type: EXPERIMENTAL
Intervention: Self-Affirmed
Number of subjects: 85

Group type: COMPARATOR
Intervention: Non-Affirmed
Number of subjects: 85
Study: 24965823

Group type: EXPERIMENTAL
Intervention: Rituximab (375 mg/m²) once weekly for 4 weeks
Number of subjects: 52

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 52

Group type: EXPERIMENTAL
Intervention: Rituximab
Number of subjects: 52
Study: 22891881

Group type: EXPERIMENTAL
Intervention: Interpersonal Psychotherapy‐Adolescent Skills Training (IPT‐AST)
Number of subjects: 98

Group type: COMPARATOR
Intervention: School Counseling (SC)
Number of subjects: 98
Study: 20179981

Group type: EXPERIMENTAL
Intervention: Avocado soybean unsaponifiable (Piascledine) 300 mg once daily
Number of subjects: 364

Group type: COMPARATOR
Intervention: Chondroitin sulfate 400 mg three times daily
Number of subjects: 364

Group type: EXPERIMENTAL
Intervention: Both treatments
Number of subjects: 364
Study: 17334380

Group type: EXPERIMENTAL
Intervention: Panel of seven markers (ApoB3HVR-D3S1358-HUM-THO1-VWF-1-D16S310-FES-VWA)
Number of subjects: 1000

Group type: EXPERIMENTAL
Intervention: Panel of seven markers
Number of subjects: 1000
Study: 15869770

Group type: EXPERIMENTAL
Intervention: Artesunate plus sulfadoxine-pyrimethamine (AS+SP)
Number of subjects: 161

Group type: EXPERIMENTAL
Intervention: Artesunate plus amodiaquine (AS+AQ)
Number of subjects: 161
Study: 12539108

Group type: EXPERIMENTAL
Intervention: Multivariate predictor derived from Cox regression analysis using patient age, sex, ejection fraction, smoking history, prior myocardial infarction history, frequency of premature beats, presence of runs of ventricular tachycardia on Holter monitoring, and time from index myocardial infarction to baseline Holter and recruitment into CAST.
Number of subjects: 200000
Study: 9857355

Group type: EXPERIMENTAL
Intervention: Two doses of 5, 10, 20 or 40 micrograms of a new hepatitis B vaccine
Number of subjects: 100

Group type: EXPERIMENTAL
Intervention: Single dose of 20 micrograms of the vaccine
Number of subjects: 100

Group type: EXPERIMENTAL
Intervention: Two doses of 20 micrograms or 40 micrograms of the vaccine formulation
Number of subjects: 100
Study: 9699448

Group type: COMPARATOR
Intervention: Vitremer
Number of subjects: 26

Group type: COMPARATOR
Intervention: Dyract Ortho
Number of subjects: 26

Group type: COMPARATOR
Intervention: Combined test materials (Vitremer and Dyract Ortho)
Number of subjects: 26

Group type: COMPARATOR
Intervention: Control (Right-On)
Number of subjects: 26
Study: 1882212

Group type: EXPERIMENTAL
Intervention: Calorie diet (approx. 25 calories/kg ideal body weight/day for 8 weeks)
Number of subjects: 12

Group type: COMPARATOR
Intervention: Exchange list diet (approx. 25 calories/kg ideal body weight/day for 8 weeks)
Number of subjects: 12
Study: 6812139

Group type: EXPERIMENTAL
Intervention: Nortriptyline
Number of subjects: 22

Group type: COMPARATOR
Intervention: Amitriptyline
Number of subjects: 22
Study: 31818636

Group type: EXPERIMENTAL
Intervention: Remote ischemic preconditioning (RIPC) applied by inflating a tourniquet on the thigh three times just after inducing anesthesia.
Number of subjects: 63

Group type: COMPARATOR
Intervention: Control group (no intervention).
Number of subjects: 63
Study: 30816066

Group type: EXPERIMENTAL
Intervention: Aerobic + COG
Number of subjects: 52

Group type: EXPERIMENTAL
Intervention: Activity + COG
Number of subjects: 52

Group type: COMPARATOR
Intervention: Activity + Games
Number of subjects: 52
Study: 28078523

Group type: EXPERIMENTAL
Intervention: Six-branches autologous sling
Number of subjects: 120

Group type: COMPARATOR
Intervention: Two-branches autologous sling
Number of subjects: 120
Study: 23375997

Group type: EXPERIMENTAL
Intervention: Chronic disease management (CDM) intervention
Number of subjects: 60

Group type: COMPARATOR
Intervention: Usual care
Number of subjects: 60
Study: 21346593

Group type: EXPERIMENTAL
Intervention: Aerobic exercise (3 months of vigorous aerobic exercise, supervised 3 times per week)
Number of subjects: 40

Group type: COMPARATOR
Intervention: Nonaerobic (no aerobic exercise)
Number of subjects: 40
Study: 19624554

Group type: EXPERIMENTAL
Intervention: Desloratadine (DL) 5 mg once daily
Number of subjects: 547

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 547

Group type: EXPERIMENTAL
Intervention: Desloratadine (DL)
Number of subjects: 547
Study: 18179991

Group type: EXPERIMENTAL
Intervention: Yearly IV bisphosphonate (zoledronic acid)
Number of subjects: 1174

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 1174
Study: 15100667

Group type: EXPERIMENTAL
Intervention: Specific immunotherapy (subcutaneous injections of a mixture of Dermatophagoides pteronyssinus and Dermatophagoides farinae vaccine; n=41)
Number of subjects: 72

Group type: COMPARATOR
Intervention: Placebo (n=31)
Number of subjects: 72
Study: 11430712

Group type: EXPERIMENTAL
Intervention: Oral E2 6-11 microg/kg/d in the evening with GH 0.1 IU/kg/d sc at bedtime
Number of subjects: 9

Group type: COMPARATOR
Intervention: Oral E2 6-11 microg/kg/d in the morning with GH 0.1 IU/kg/d sc at bedtime
Number of subjects: 9
Study: 9209553

Group type: EXPERIMENTAL
Intervention: 0.5 g/kg alcohol dose
Number of subjects: 10

Group type: EXPERIMENTAL
Intervention: 1.0 g/kg alcohol dose
Number of subjects: 10

Group type: EXPERIMENTAL
Intervention: Breath alcohol concentrations
Number of subjects: 10

Group type: EXPERIMENTAL
Intervention: Blood alcohol concentrations
Number of subjects: 10
Study: 8444538

Group type: EXPERIMENTAL
Intervention: Topical phenytoin
Number of subjects: 75

Group type: COMPARATOR
Intervention: Conventional saline dressings
Number of subjects: 75
Study: 3695636

Group type: EXPERIMENTAL
Intervention: Modeling videotape with a patient asking questions
Number of subjects: 150

Group type: EXPERIMENTAL
Intervention: Modeling videotape with a patient revealing problems
Number of subjects: 150

Group type: COMPARATOR
Intervention: Control videotape with only the educator's presentation
Number of subjects: 150

Group type: EXPERIMENTAL
Intervention: Both modeling conditions
Number of subjects: 150
Study: 29406821

Group type: EXPERIMENTAL
Intervention: Goiter dispersion formula and antithyroid drugs (methimazole or propylthiouracil)
Number of subjects: 80

Group type: COMPARATOR
Intervention: Antithyroid drug alone
Number of subjects: 80
Study: 28606450

Group type: EXPERIMENTAL
Intervention: Hourly recorded messages in a family member's voice during waking hours over 3 ICU days
Number of subjects: 30

Group type: EXPERIMENTAL
Intervention: Hourly recorded messages in a non-family voice during waking hours over 3 ICU days
Number of subjects: 30

Group type: COMPARATOR
Intervention: No automated reorientation messages (control group)
Number of subjects: 30
Study: 24847017

Group type: EXPERIMENTAL
Intervention: Biolimus-eluting stent (BES)
Number of subjects: 1161

Group type: COMPARATOR
Intervention: Bare-metal stents (BMS)
Number of subjects: 1161
Study: 22840975

Group type: EXPERIMENTAL
Intervention: Midurethral sling surgery (retropubic and transobturator)
Number of subjects: 597

Group type: EXPERIMENTAL
Intervention: Preoperative urge incontinence
Number of subjects: 597

Group type: EXPERIMENTAL
Intervention: Postoperative urge incontinence
Number of subjects: 597
Study: 20523044

Group type: EXPERIMENTAL
Intervention: PS-DHA
Number of subjects: 157

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 157
Study: 19211942

Group type: EXPERIMENTAL
Intervention: Arms-only swimming training (ES)
Number of subjects: 15

Group type: COMPARATOR
Intervention: Control group (CS)
Number of subjects: 15
Study: 15928361

Group type: EXPERIMENTAL
Intervention: Cognitive therapy plus standard treatment
Number of subjects: 103

Group type: COMPARATOR
Intervention: Standard treatment
Number of subjects: 103
Study: 12568062

Group type: EXPERIMENTAL
Intervention: Basic Reading Through Dance program (20 sessions)
Number of subjects: 721

Group type: COMPARATOR
Intervention: Control group (no intervention)
Number of subjects: 721
Study: 10584135

Group type: EXPERIMENTAL
Intervention: Radiochemotherapy and amifostine (RCT + A)
Number of subjects: 47

Group type: COMPARATOR
Intervention: Radiochemotherapy (RCT)
Number of subjects: 47
Study: 8733931

Group type: EXPERIMENTAL
Intervention: Condition that alerted participants to the gender of the names in Experiment 1
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Participants' sex-role orientation in Experiment 2
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Process dissociation procedure used in both experiments
Number of subjects: 0
Study: 1794297

Group type: EXPERIMENTAL
Intervention: L-carnitine (2 g orally daily for 6 months)
Number of subjects: 200
Study: 6844192

Group type: EXPERIMENTAL
Intervention: Lysine theophylline
Number of subjects: 0

Group type: COMPARATOR
Intervention: Aminophylline
Number of subjects: 0
Study: 30635256

Group type: EXPERIMENTAL
Intervention: Fronto-temporal tDCS (2-mA, twice-daily sessions for 5 days)
Number of subjects: 60
Study: 29280483

Group type: EXPERIMENTAL
Intervention: Continuous 3,4-DAP
Number of subjects: 32

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 32
Study: 27534747

Group type: EXPERIMENTAL
Intervention: Dydrogesterone 40 mg per os, followed by 10 mg per os three times a day until twelve completed weeks of gestation or 1 week after the bleeding has stopped, whichever is longer.
Number of subjects: 400

Group type: COMPARATOR
Intervention: Placebo until twelve completed weeks of gestation or 1 week after the bleeding has stopped, whichever is longer.
Number of subjects: 400
Study: 24833680

Group type: EXPERIMENTAL
Intervention: Day unit rehabilitation
Number of subjects: 306

Group type: EXPERIMENTAL
Intervention: Home rehabilitation
Number of subjects: 306

Group type: COMPARATOR
Intervention: Control group (traditional treatment)
Number of subjects: 306
Study: 22228393

Group type: EXPERIMENTAL
Intervention: Home-based walking intervention
Number of subjects: 126

Group type: COMPARATOR
Intervention: Control group (no intervention)
Number of subjects: 126
Study: 19636975

Group type: EXPERIMENTAL
Intervention: Ambroxol (90 mg, three times per day for 3 months)
Number of subjects: 120

Group type: COMPARATOR
Intervention: Control (no ambroxol treatment)
Number of subjects: 120
Study: 19241647

Group type: EXPERIMENTAL
Intervention: Auricular acupuncture
Number of subjects: 185

Group type: COMPARATOR
Intervention: Control group (no acupuncture)
Number of subjects: 185
Study: 16316362

Group type: EXPERIMENTAL
Intervention: IV iron sucrose (1 g in divided IV doses over 14 days)
Number of subjects: 0

Group type: COMPARATOR
Intervention: Oral iron (ferrous sulfate, 325 mg orally thrice daily for 56 days)
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: IV iron sucrose (200 mg IV over two to five minutes)
Number of subjects: 0
Study: 12428232

Group type: EXPERIMENTAL
Intervention: Hematopoietic stem cell transplantation (HSCT)
Number of subjects: 15
Study: 9594486

Group type: EXPERIMENTAL
Intervention: Salmeterol xinafoate inhaled twice daily
Number of subjects: 0
Study: 7648155

Group type: EXPERIMENTAL
Intervention: Ultrasonographic screening for abdominal aortic aneurysm (AAA)
Number of subjects: 15775

Group type: COMPARATOR
Intervention: Age- and sex-matched controls (no screening)
Number of subjects: 15775
Study: 2526364

Group type: EXPERIMENTAL
Intervention: Inpatient treatment
Number of subjects: 459

Group type: EXPERIMENTAL
Intervention: Outpatient treatment
Number of subjects: 459

Group type: COMPARATOR
Intervention: Control group
Number of subjects: 459
Study: 941943

Group type: EXPERIMENTAL
Intervention: Estrogen results reported (Group A)
Number of subjects: 622

Group type: COMPARATOR
Intervention: Estrogen results not reported (Group B)
Number of subjects: 622
Study: 31574114

Group type: EXPERIMENTAL
Intervention: Intravenous (IV) infusion of 10 IU oxytocin
Number of subjects: 480

Group type: COMPARATOR
Intervention: Intramuscular (IM) injection of 10 IU oxytocin
Number of subjects: 480
Study: 28065368

Group type: EXPERIMENTAL
Intervention: Computed tomography (CT)
Number of subjects: 300

Group type: COMPARATOR
Intervention: Selective imaging practice (SIP)
Number of subjects: 300
Study: 25583494

Group type: EXPERIMENTAL
Intervention: Environment and health-based information strategies
Number of subjects: 118

Group type: COMPARATOR
Intervention: Monetary savings information
Number of subjects: 118
Study: 23537587

Group type: EXPERIMENTAL
Intervention: Reduced toxicant prototype (RTP) cigarettes
Number of subjects: 0

Group type: COMPARATOR
Intervention: Conventional cigarettes
Number of subjects: 0
Study: 21723131

Group type: EXPERIMENTAL
Intervention: Gait report group (N=90)
Number of subjects: 178
Study: 19619427

Group type: EXPERIMENTAL
Intervention: ART restorations with cavity conditioner
Number of subjects: 48

Group type: COMPARATOR
Intervention: ART restorations without cavity conditioning
Number of subjects: 48
Study: 16842029

Group type: EXPERIMENTAL
Intervention: Ocular correction modified through electromyographic control (study group)
Number of subjects: 32

Group type: COMPARATOR
Intervention: Conventional ocular correction (control group)
Number of subjects: 32
Study: 12970782

Group type: EXPERIMENTAL
Intervention: Interferon α (IFN)
Number of subjects: 199

Group type: COMPARATOR
Intervention: Hydroxyurea (HU)
Number of subjects: 199

Group type: COMPARATOR
Intervention: Busulfan (BU)
Number of subjects: 199
Study: 10869871

Group type: EXPERIMENTAL
Intervention: Gamma-hydroxybutyric acid
Number of subjects: 321

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 321
Study: 8884582

Group type: EXPERIMENTAL
Intervention: Behavioural relaxation training
Number of subjects: 20

Group type: COMPARATOR
Intervention: Quiet reading period (Control)
Number of subjects: 20
Study: 1543592

Group type: EXPERIMENTAL
Intervention: Muscle glycogen depletion (protocol 1)
Number of subjects: 17

Group type: EXPERIMENTAL
Intervention: Ramp exercise test at different rates of increasing work rate (protocol 2)
Number of subjects: 17

Group type: COMPARATOR
Intervention: Control days (days 1 and 3 in protocol 1)
Number of subjects: 17
Study: 3161703

Group type: EXPERIMENTAL
Intervention: Diflunisal once daily (500 mg or 1000 mg)
Number of subjects: 235

Group type: COMPARATOR
Intervention: Diflunisal twice daily
Number of subjects: 235